Abstrak
Analysis of chemical composition and its analgesic and antiinflammatory activity of essential oil of sintoc bark (Cinnamomumsintoc bl.) using in vivo methods
Sri Adi Sumiwi, Anas Subarnas, Supriyatna Supriyatna, Marline Abdasah, Muchtaridi Muchtaridi
Universitas Padjadjaran, Journal of Applied Pharmaceutical Science Vol. 5 (02), pp. 058-065, February, 2015 Available online at https://www.japsonline.com DOI: 10.7324/JAPS.2015.50209 ISSN 2231-3354
Bahasa Inggris
Universitas Padjadjaran, Journal of Applied Pharmaceutical Science Vol. 5 (02), pp. 058-065, February, 2015 Available online at https://www.japsonline.com DOI: 10.7324/JAPS.2015.50209 ISSN 2231-3354
Analgesic, Anti-inflammatory, Eugenol, Sintoc bark oils
Sintoc bark (Cinnamomum sintoc Bl) belongs to Lauraceae (the laurel family). It has been used empirically for a treatment for swelling caused by insects’ bites. In this study, the research examined the analgesic activity and anti-inflammation of essential oil of sintocbark using in vivo methods. The mechanism of anti-inflammation was predicted using molecular docking against COX-2. Essential oil of sintoc bark was collected by distilling through steam distillation, and then analyzed by GC-MS. Analgesic and anti-inflammatory activity was examined by in vivo, which were conducted by writhing and carrageenan-induced methods, respectively. The findings showed that the tested sintoc bark oils contained 36 components of essential oil with eugenol (38.38 %) as a major compound. In the in vivo experiments, sintoc bark oils with doses 0.005 mL, 0.010 mL, and 0.020 mL/20g body weight significantly (p<0.05) reduced the number of writhing of mice when compared to negative control group. All of doses of sintoc bark oils gave significantly affect (confidence level 99 %) compare to negative control. Sintoc oil with dose 0.2 ml/200g had the strongest inhibition compare to positive control (indometasin 10 mg/kg body weight). The molecular docking results indicated that the compounds of aryl propanoid were generally potential to inhibit COX-2.